Navigation Links
A new weapon in the fight against obesity and diabetes
Date:11/4/2008

This press release is available in French.

A study appearing November 5 in the journal Cell Metabolism demonstrates that a synthetic new chemical entity protects against diet-induced obesity, improves glucose tolerance and insulin sensitivity and enhances exercise endurance by enhancing fat utilization in certain target tissues.

The new chemical entity was developed by Sirtris, a a GSK company, and the research study was led by EPFL professor Johan Auwerx, MD.

Reducing calorie consumption by about 20% has been shown to slow down the aging process, improve endurance and protect against diet-induced obesity and metabolic diseases such as diabetes. A year ago, researchers demonstrated that these metabolic benefits can also occur with large doses of resveratrol, a substance naturally occurring in red wine. Researchers hypothesized that these beneficial effects result from activation of SIRT1, an enzyme that is involved in regulating certain key cellular processes, notably the efficiency and number of mitochondria the energy powerhouses of our cells.

Because dietary management and exercise rarely succeed by themselves in curbing obesity and associated metabolic disorders, interest has increased in using the SIRT1 pathway as a target for possible pharmacological intervention.

The new chemical entity announced today in Cell Metabolism was specifically designed to activate the SIRT1 pathway and assess its role in the beneficial metabolic effects found in calorie restriction and high doses of resveratrol. The new research verified the hypothesis, demonstrating that activating the SIRT1 pathway protects from diet-induced obesity and its negative metabolic consequences by primarily promoting fat consumption in skeletal muscle, liver, and brown adipose tissue.

"These results show that new synthetic SIRT1 activators can
'/>"/>

Contact: Johan Auwerx
johan.auwerx@epfl.ch
41-216-930-951
Ecole Polytechnique Fdrale de Lausanne
Source:Eurekalert

Page: 1 2

Related biology news :

1. Argonne scientists peer into heart of compound that may detect chemical, biological weapons
2. Researcher working on destruction of chemical weapons
3. Francisella tularensis: Stopping a biological weapon
4. UD plant biologists uncover top wetland plants hidden weapon
5. Scripps Florida scientists awarded $1.5M to fight major water and food parasites
6. UCSB study finds physical strength, fighting ability revealed in human faces
7. Plant-eating predator to fight superweed is not magic bullet
8. Vitiligo skin disorder could yield clues in fight against melanoma
9. Anti-tumor therapy with endoscopic ultrasound may fight cancer more safely and effectively
10. Synthetic moleculues could add spice to fight against cancer
11. Potential new drug target to fight tuberculosis identified
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/13/2015)... April 13, 2015  higi, a leading cloud-based consumer ... more fully engage with their communities around health and ... protected and secure API.  ... most accessible, affordable, and convenient vehicle to receive validated ... The API will allow higi,s trusted ...
(Date:4/8/2015)... N.C. , April 8, 2015  Infinisource, ... solutions and services, and Morpho, a leading supplier ... partnership to produce the market,s most advanced biometrically-enabled ... Infinisource,s iSolved NXG time clock is setting a ... and labor data for the small and mid-size ...
(Date:4/2/2015)... -- At its 2015 ACMG Annual Clinical Genetics Meeting ... American College of Medical Genetics and Genomics (ACMG) announced ... Members of the ACMG Board of Directors serve as ... its policies and programs. ACMG is the national organization ... eventful time in medical genetics and genomics.  We are ...
Breaking Biology News(10 mins):higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 2higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 3iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 3American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 2American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 3American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 4American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 5American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 6American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 7American College of Medical Genetics and Genomics Announces New Board Members: Dr. Louanne Hudgins is ACMG President-Elect 8
... essential nutrient and a pollutant, a byproduct of fossil ... benefit and a hazard, depending on form, location, and ... around the planet, say sixteen scientists in the latest ... "Excess Nitrogen in the U.S. Environment: Trends, Risks, and ...
... simple experiment, University of Illinois chemists have debunked a ... by chemistry professor and Howard Hughes Medical Institute early ... top drug for treating systemic fungal infections works by ... physiology, a finding that could change the direction of ...
... sex of a fetus until after 30 weeks of pregnancy ... groups in Canada and the United States, states an editorial ... Female feticide that is, choosing to abort female ... issue in several Asian countries including India, China, Korea and ...
Cached Biology News:Solutions for a nitrogen-soaked world 2Powerful drug's surprising, simple method could lead to better treatments 2Powerful drug's surprising, simple method could lead to better treatments 3Female feticide in Canada requires action 2
(Date:5/1/2015)... 2015 Pfenex Inc. (NYSE MKT: PFNX), ... of biosimilar therapeutics including high value and difficult ... quarter 2015 financial results will be released on ... market. At 8:30 am Eastern Time, Pfenex management will ... results and provide a business update. A press release ...
(Date:5/1/2015)... LONDON , May 1, 2015 ... world market for antithrombotic drugs will reach $22.4bn in ... Antithrombotic Drugs: World Industry and Market Prospects 2015-2025 ... purpose of that investigation is to provide forecasts and ... a business information publisher and consultancy in ...
(Date:5/1/2015)... , May 1, 2015 Albany Molecular ... William S. Marth , AMRI,s President and Chief ... Merrill Lynch 2015 Health Care Conference on Wednesday, May ... live audio webcast of the presentation can be accessed ... The webcast will be archived for ...
(Date:5/1/2015)... and RESEARCH TRIANGLE PARK, N.C. ... UTHR ) announced today that Roger Jeffs , Ph.D., ... an overview and update on the company,s business at the ... Boston, Massachusetts . The presentation ... PM Eastern Time, and can be accessed via a live ...
Breaking Biology Technology:Pfenex To Report First Quarter 2015 Results and Provide Business Update on Thursday, May 14, 2015 2Antithrombotic Drugs: World Industry and Market Prospects 2015-2025 2Antithrombotic Drugs: World Industry and Market Prospects 2015-2025 3Antithrombotic Drugs: World Industry and Market Prospects 2015-2025 4Antithrombotic Drugs: World Industry and Market Prospects 2015-2025 5AMRI to Present at the Bank of America Merrill Lynch 2015 Health Care Conference 2
... 2011 Bio-Research Products announced today that it is adding ... its product line. The new Glutathione Reductase offers customers a ... liquid (#801) GR enzyme. Both versions are free of ammonium ... IU/mg protein and an enzyme activity of 300 IU/mL. ...
... Inc. (OTCBB: UGNE), a leader in ... announced that Ashleigh Palmer, President and Chief Executive Officer, ... Annual Oppenheimer Healthcare Conference being held in New York ... 4:10 p.m. ET on Tuesday, December 13, 2011. ...
...  Coronado Biosciences, Inc., (OTCBB: CNDO), a biopharmaceutical company ... for the treatment of autoimmune diseases and cancer, ... the Company,s President, Chief Executive Officer and Director, ... Conference on Wednesday, December 14, 2011 at 10:30 ...
Cached Biology Technology:Unigene to Present at the Oppenheimer 22nd Annual Healthcare Conference on December 13, 2011 2Coronado Biosciences to Present at the Oppenheimer 22nd Annual Healthcare Conference 2